I agree that this site is using cookies. You can find further informations here.
X
Nassar, Amin H.
1091  results:
Search for persons X
?
1

Clinical outcomes and safety of immune checkpoint inhibitor..:

Nassar, Amin H ; El Zarif, Talal ; Khalid, Ahmed Bilal...
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e008724 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Response letter by Nassar et al:

Nassar, Amin H. ; Kim, So Yeon ; Adib, Elio..
Journal of Thoracic Oncology.  19 (2024)  5 - p. e7-e8 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Clinical Outcomes Among Immunotherapy-Treated Patients With..:

Nassar, Amin H. ; El-Am, Edward ; Denu, Ryan...
JACC: CardioOncology.  6 (2024)  1 - p. 71-79 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Benchmarking mismatch repair testing for patients with canc..:

Bou Farhat, Elias ; Adib, Elio ; Daou, Melissa...
Cancer Cell.  42 (2024)  1 - p. 6-7 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Real-World Multicenter Study of PD-1 Blockade in HIV-Associ..:

Lurain, Kathryn ; Zarif, Talal El ; Ramaswami, Ramya...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

Consolidation Osimertinib Versus Durvalumab Versus Observat..:

Nassar, Amin H. ; Kim, So Yeon ; Aredo, Jacqueline V....
Journal of Thoracic Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
7

Treatment-related adverse events, including fatal toxicitie..:

Fujiwara, Yu ; Horita, Nobuyuki ; Adib, Elio...
The Lancet Oncology.  25 (2024)  1 - p. 62-75 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Benchmarking mismatch repair testing for patients with canc..:

Bou Farhat, Elias ; Adib, Elio ; Daou, Melissa...
Cancer Cell.  42 (2024)  2 - p. 323 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Mismatch repair deficiency and microsatellite instability i..:

Chandran, Elias B A ; Iannantuono, Giovanni Maria ; Atiq, Saad O...
BMJ Oncology.  3 (2024)  1 - p. e000335 , 2024
Link: https://doi.org/10.1136/..
 
?
10

Editorial: Methods in genitourinary oncology:

Jang, Albert ; Sella, Avishay ; Nassar, Amin H..
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
11

Safety and efficacy of immune checkpoint inhibitors in adva..:

El Zarif, Talal ; Nassar, Amin H ; Pond, Gregory R...
JNCI: Journal of the National Cancer Institute.  115 (2023)  12 - p. 1605-1615 , 2023
Link: https://doi.org/10.1093/..
 
?
12

Epigenomic profiling nominates master transcription factors..:

El Zarif, Talal ; Semaan, Karl ; Eid, Marc...
The Oncologist.  28 (2023)  Supplement_1 - p. S8-S8 , 2023
Link: https://doi.org/10.1093/..
 
?
13

TERT Promoter Mutations Frequency Across Race, Sex, and Can..:

El Zarif, Talal ; Machaalani, Marc ; Nawfal, Rashad...
The Oncologist.  29 (2023)  1 - p. 8-14 , 2023
Link: https://doi.org/10.1093/..
 
?
14

Epigenomic charting and functional annotation of risk loci ..:

Nassar, Amin H. ; Abou Alaiwi, Sarah ; Baca, Sylvan C....
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
15

Prevalence of pathogenic germline cancer risk variants in t..:

Ramamurthy, Chethan ; Nassar, Amin H. ; Abou Alaiwi, Sarah...
Urologic Oncology: Seminars and Original Investigations.  40 (2022)  3 - p. 113.e9-113.e15 , 2022
Link: https://doi.org/10.1016/..
 
1-15